High EGFR gene copy number predicts poor outcome in triple-negative breast cancer. (Q53300836)

13 May 2018

title

High EGFR gene copy number predicts poor outcome in triple-negative breast cancer. (English)

1 reference

13 May 2018

author name string

Heae Surng Park

1

1 reference

13 May 2018

Min Hye Jang

2

1 reference

13 May 2018

Eun Joo Kim

3

1 reference

13 May 2018

Hyun Jeong Kim

4

1 reference

13 May 2018

Hee Jin Lee

5

1 reference

13 May 2018

Yu Jung Kim

6

1 reference

13 May 2018

Jee Hyun Kim

7

1 reference

13 May 2018

Eunyoung Kang

8

1 reference

13 May 2018

Sung-Won Kim

9

1 reference

13 May 2018

In Ah Kim

10

1 reference

13 May 2018

So Yeon Park

11

1 reference

13 May 2018

publication date

10 January 2014

1 reference

13 May 2018

published in

Modern Pathology

1 reference

13 May 2018

volume

27

1 reference

13 May 2018

issue

9

1 reference

13 May 2018

page(s)

1212-1222

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2013.251

exact match

0 references

cites work

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Epidermal growth factor receptor abnormalities in lung cancer. Pathogenetic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

The biology of epidermal growth factor receptor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Amplified cellular oncogenes in neoplasms of the human central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

EGFR expression and gene copy number in triple-negative breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

The effect of chromosome 17 polysomy on HER-2/neu status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Role of epidermal growth factor receptor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

Triple negative tumours: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

inferred from DOI database lookup

7 January 2021

based on heuristic

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

inferred from DOI database lookup

7 January 2021

based on heuristic

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2013.251

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.2013.251

1 reference

13 May 2018

PubMed ID

24406864

1 reference

13 May 2018